Whitehawk Therapeutics (WHWK)

• Market cap: $108M
• 1 day: 6.98%
• 5 days: 10.05%
• 1 month: -4.96%
• 3 months: 27.07%
• 6 months: 27.78%
• Year to date: -26.75%
• 1 year: -0.43%
• 5 years: -90.53%
• 10 years: -96.07%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 22